Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Cochet

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
British Journal of Cancer|March 23, 2018
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinomaHelena Polena, Julie Creuzet, Maeva Dufies, et al.
Nature Immunology|January 3, 2024
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayAnn Y Park, Michael Leney-Greene, Matthew Lynberg, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
British Journal of Cancer|March 23, 2018
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinomaHelena Polena, Julie Creuzet, Maeva Dufies, et al.
Nature Immunology|January 3, 2024
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathwayAnn Y Park, Michael Leney-Greene, Matthew Lynberg, et al.
Pageof 7